Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
100.60    -0.80 (-0.79%)
Bid:
99.90
Ask:
101.20
Spread: 1.30 (1.301%)
Market Cap: £122.23m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Director/PDMR Shareholding

7 Dec 2020 15:47

RNS Number : 8173H
Impax Asset Management Group plc
07 December 2020
Β 

7 December 2020

Β 

Impax Asset Management Group plc

Director / PDMR disclosure

Grant of shares

Impax Asset Management Group plc (the "Company") announces that it has awarded grants under the Company's restricted share scheme ("RSS") to the following PDMRs:

PDMR

Number of shares granted under RSS Award

Date of Grant

Ian Simm

20,000

7 December 2020

One-third of the Shares will vest in three years, a further third will vest in four years and the final third will vest in five years.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Β 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Ian Simm

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Impax Asset Management Group plc

b)

LEI

213800AJDNW4S2B7E680

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of financial instrument

Identification Code

Ordinary Shares of 1p each in Impax Asset Management Group plc

Β 

IPX

GB0004905260

b)

Nature of the transaction

Ian Simm has been awarded 20,000 restricted ordinary shares.

Β 

One-third of the Shares will vest in three years, a further third will vest in four years and the final third will vest in five years.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0p (nil) per share

20,000

d)

Aggregated information

Aggregated volume

Price

Aggregated volume: 20,000

Β 

Aggregated price: 0p (nil)

Β 

Total aggregated price: 0p (nil)

Β 

e)

Date of the transaction

7 December 2020

Β 

f)

Place of the transaction

Β 

Outside of trading venue

Β 

LEI number: 213800AJDNW4S2B7E680

-ENDS-

Β 

Impax Asset Management Group plc

Ian Simm, Chief Executive

Paul French, Corporate Communications Director

Β 

Β 

+44 (0)20 3912 3000

Montfort Communications

Gay Collins

Louis Supple

impax@montfort.london

Β 

Β 

+44 (0)77 9862 6282

+44 (0)77 3943 0102

Peel Hunt LLP, Nominated Adviser

James Britton or Rishi Shah

Β 

+44 (0)20 7418 8900

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFLFSEFELDIII
Date   Source Headline
31st May 20237:00 amRNSHalf-year Report
26th May 20233:10 pmRNSInvestment Advisory Agreement
26th May 20237:00 amRNSHolding(s) in Company
23rd May 20237:00 amRNSInvestor Presentation of Interim Results
15th May 20232:25 pmRNSHolding(s) in Company
9th May 20237:00 amRNSNotice of Results
11th Apr 20237:00 amRNSQ2 AUM Update
16th Mar 20231:57 pmRNSDirectorate Changes
16th Mar 20231:56 pmRNSResult of AGM
15th Mar 20238:43 amRNSHolding(s) in Company
9th Jan 20237:00 amRNSQ1 AUM update
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20223:33 pmRNSHolding(s) in Company
16th Dec 20224:46 pmRNSNotice of AGM
13th Dec 20223:02 pmRNSHolding(s) in Company
1st Dec 20225:06 pmRNSPublication of Annual Financial Report
1st Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSFinal Results
25th Nov 20227:00 amRNSinvestor Presentation of Full Year Results
23rd Nov 20227:00 amRNSNotice of results
21st Nov 20225:05 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSAUM update
3rd Oct 20228:22 amRNSHolding(s) in Company
13th Sep 202210:49 amRNSHolding(s) in Company
9th Sep 20221:32 pmRNSHolding(s) in Company
2nd Sep 20223:34 pmRNSHolding(s) in Company
12th Aug 20229:37 amRNSDirector/PDMR Shareholding
21st Jul 20225:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSAUM update
6th Jul 20221:50 pmRNSDirector/PDMR and PCA Shareholding
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSBoard Appointment
16th Jun 20224:37 pmRNSDirector/PDMR and PCA Shareholding
14th Jun 20227:00 amRNSHolding(s) in Company
7th Jun 20224:36 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSInterim results to 31 March 2022
12th May 20228:16 amRNSHolding(s) in Company
12th May 20227:00 amRNSInvestor Presentation of Interim Results
6th May 20227:00 amRNSDate of Interim Results
26th Apr 20223:37 pmRNSHolding(s) in Company
20th Apr 20222:11 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSAUM update
30th Mar 20222:14 pmRNSDirector/PDMR Shareholding
29th Mar 20226:10 pmRNSResult of AGM
4th Mar 20222:30 pmRNSDirector/PDMR and PCA Shareholding
25th Feb 20227:00 amRNSAIM Rule 17 Schedule Two (g) Update
14th Feb 20221:24 pmRNSDistribution agreement
10th Jan 20227:00 amRNSAUM update
20th Dec 20216:04 pmRNSNotice of Annual General Meeting ("AGM")
20th Dec 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.